Top Legislation - View All
Also tagged in: Commemorations, Congressional tributes, Copyright, Creative thinking, Economic growth, Economic policy, Foreign policy, Fraud, Intellectual property, International affairs, International agencies, Patent infringement, Special days, Technological innovations, Technology, Trademarks
Latest Action: 04/25/2007 - Committee Consideration and Mark-up Session Held. Bill TextSupporting the goals of World Intellectual Property Day, and for other purposes. 4/17/2007--Introduced. Expresses support for: (1) the goals of World Intellectual Property Day to promote, inform, and teach the importance of intellectual property as a tool for economic, social, and cultural development; and (2) efforts to protect U.S. citizens from fraudulent and illegal counterfeiting and piracy. Recognizes the importance of intellectual property and the challenges and threats to its protection. Congratulates the World Intellectual Property Organization for building awareness of the value of intellectual property and developing the infrastructure to help citizens take full advantage of their creativity. Applauds the contributions of human creativity and intellectual property to growth, innovation, and a brighter future.
Also tagged in: Accreditation (Medical care), Actions and defenses, Administrative fees, Administrative procedure, Administrative remedies, Aged, Appropriations, Armed forces, Auditing, Australia, Budgets, Business, Business records, Canada, Capital gains tax, Caribbean area, Checks, Citizenship, Civil liberties, Claims, Competitive bidding, Conflict of interests, Congress, Congressional reporting requirements, Consumer education, Consumers, Continental shelf, Contracts, Corporation taxes, Cost of living adjustments, Courts of special jurisdiction, Credit cards, Criminal justice, Cuba, Customs administration, Damages, Data banks, Defective products, Defense contracts, Defense economics, Department of Defense, Department of Health and Human Services, Department of Homeland Security, Department of the Interior, Department of the Treasury, Directories, Disciplining of employees, Dividends, Drug advertising, Drug approvals, Drug industry, Drugs, Due process of law, East Asia, Education, Electronic commerce, Electronic data interchange, Electronic funds transfers, Electronic government information, Employee rights, Energy, Environmental Protection Agency, Europe, European Union, Evidence (Law), Executive departments, Expatriation, Export controls, Exports, Federal Emergency Management Agency, Federal employees, Federal officials, Federal preemption, Federal Trade Commission, Federal-state relations, Fees, Finance, Fines (Penalties), Food and Drug Administration (FDA), Foreign corporations, Foreign policy, Foreign tax credit, Forfeiture, Fraud, Gas in submerged lands, General Services Administration, Gifts, Government contractors, Government employees, Government information, Government paperwork, Government procurement, Government publicity, Government spending reductions, Governmental investigations, Gulf of Mexico, Health policy, Higher education, Identification devices, Immigration, Import restrictions, Imports, Income tax, Independent regulatory commissions, Indexing (Economic policy), Infrastructure, Infrastructure (Economics), Injunctions, Intellectual property, Intelligence activities, Interactive media, International broadcasting, Internet, Japan, Judicial review, Jurisdiction, Labeling, Latin America, Law, Legal fees, Liability (Law), Licenses, Lobbying, Medical associations, Medical care, Medical education, Medical records, Medical tests, Medicare, Medicine, Minimum tax, New Zealand, Oceania, Office of Government Ethics, Office of Management and Budget, Office of Special Counsel, Oil and gas leases, Oil and gas royalties, Oil well drilling, Overhead costs, Packaging, Parties to actions, Patent infringement, Patents, Petroleum in submerged lands, Pharmaceutical research, Pharmacies, Pharmacists, Physical examinations, Politics and government, Prescription pricing, Presidential appointments, Presidents, Price discrimination, Profit, Public contracts, Restrictive trade practices, Right of privacy, Science policy, Security clearances, State and local government, State laws, Sunset legislation, Surety and fidelity, Switzerland, Tax deductions, Tax deferral, Tax exclusion, Tax exemption, Tax liens, Tax rates, Tax shelters, Taxation of foreign income, Technology, Telecommunication, Telephone, Television broadcasting, Trade, User charges, Web sites, Whistle blowing, Wholesale trade
Latest Action: 02/12/2007 - Sponsor introductory remarks on measure. (CR S1855-1857) Bill TextA bill to reduce the Federal budget deficit, and for other purposes. 2/12/2007--Introduced. Act for Our Kids - Repeals the Television Broadcasting to Cuba Act. Amends the Cuban Liberty and Democratic Solidarity (LIBERTAD) Act of 1996 to prohibit federal funding of television broadcasting to Cuba. Terminates the U.S. Court of Federal Claims. Requires federal agencies to reduce administrative expenses. Eliminates the Medicare Advantage Regional Plan Stabilization (SLUSH) Fund. Amends the federal criminal code to prohibit profiteering and fraud involving a contract or the provision of goods or services in connection with a war or military action. Requires: (1) suspension and debarment of unethical contractors; (2) disclosure by federal agencies, upon request, to the appropriate committee chairman or ranking member of audit reports regarding federal contractors; and (3) public access to information on federal contractor penalties and [...] show full description
Also tagged in: Administrative procedure, Administrative remedies, Advertising, Agriculture, Budgets, Business, Business records, Cancer, Carcinogens, Cardiovascular diseases, Chemicals, Child health, Children, Cigarettes, Civil liberties, Communications, Congress, Congressional investigations, Congressional oversight, Congressional powers, Congressional reporting requirements, Consumer education, Consumers, Criminal justice, Damages, Deceptive advertising, Defective products, Dental care, Department of Health and Human Services, Disciplining of employees, Drug abuse, Drug abuse treatment, Drug adulteration, Drug approvals, Executive departments, Exports, Federal advisory bodies, Federal preemption, Federal Trade Commission, Fines (Penalties), Food and Drug Administration (FDA), Freedom of information, Government information, Government paperwork, Government publicity, Hazardous substances, Health policy, Health warnings, Herbs, Identification devices, Imports, Independent regulatory commissions, Intellectual property, Judicial review, Labeling, Labor, Law, Liability (Law), Licenses, Local laws, Lung cancer, Lung diseases, Marketing, Medical care, Medical ethics, Medical records, Medical research, Medicine, Mortality, New products, Nicotine, Packaging, Patients' rights, Pesticides, Pregnant women, Product safety, Public health, Public service advertising, Quality control, Research and development, Restrictive trade practices, Retail trade, Right of privacy, Risk, Sales promotion, Science policy, Smokeless tobacco, Smoking, Smoking and youth, Smuggling, Spices, Standards, State and local government, State laws, Storage, Stroke, Surveys, Tax returns, Taxation, Technological innovations, Technology, Tobacco, Tobacco exports, Tobacco industry, Tobacco research, Trade, Trade regulation, Trade secrets, Trademarks, User charges, Warning labels, Women, Women's health
Latest Action: 08/01/2007 - Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. Bill TextA bill to protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products. 2/15/2007--Introduced. Family Smoking Prevention and Tobacco Control Act - Amends the Federal Food, Drug, and Cosmetic Act to provide for the regulation of tobacco products by the Secretary of Health and Human Services through the Food and Drug Administration, including through disclosure, annual registration, inspection, recordkeeping, and user fee requirements. Sets forth criteria by which tobacco products are deemed adulterated or misbranded. Allows the Secretary to require prior approval of all label statements. Allows the Secretary to restrict the sale or distribution of tobacco products, including advertising and promotion, if the Secretary determines that such regulation would be appropriate for the protection of the public health. Prohibits such regulations from: (1) limiting product sales or distribution to authorization [...] show full description
Also tagged in: Consumers, Criminal justice, Death, Drug adulteration, Drugs, Fines (Penalties), Fraud, Labeling, Medical care, Medicine, Sentences (Criminal procedure)
Latest Action: 03/01/2007 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act with respect to counterfeit drugs, and for other purposes. 1/31/2007--Introduced. Counterfeit Drug Prevention Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to establish criminal penalties of a fine and imprisonment for not more than 20 years, or both, for any person who commits a prohibited act relating to counterfeiting knowing that: (1) the conduct concerns the rendering of a drug as a counterfeit drug; (2) the conduct will cause a drug to be a counterfeit drug; or (3) a drug, held, sold, or dispensed is a counterfeit drug. Increases the term of imprisonment to any term of years or for life if the use of a counterfeit drug is the proximate cause of a consumer's death. Modifies provisions pertaining to criminal fines for committing certain prohibited acts involving food, drugs, devices, or cosmetics.
Also tagged in: Administrative procedure, Administrative remedies, Advertising, Agriculture, Budgets, Business, Business records, Cancer, Carcinogens, Cardiovascular diseases, Chemicals, Child health, Children, Cigarettes, Civil liberties, Communications, Congress, Congressional investigations, Congressional oversight, Congressional powers, Congressional reporting requirements, Consumer education, Consumers, Criminal justice, Damages, Deceptive advertising, Defective products, Dental care, Department of Health and Human Services, Disciplining of employees, Drug abuse, Drug abuse treatment, Drug adulteration, Drug approvals, Executive departments, Exports, Federal advisory bodies, Federal preemption, Federal Trade Commission, Fines (Penalties), Food and Drug Administration (FDA), Freedom of information, Government information, Government paperwork, Government publicity, Hazardous substances, Health policy, Health warnings, Herbs, Identification devices, Imports, Independent regulatory commissions, Intellectual property, Judicial review, Labeling, Labor, Law, Liability (Law), Licenses, Local laws, Lung cancer, Lung diseases, Marketing, Medical care, Medical ethics, Medical records, Medical research, Medicine, Mortality, New products, Nicotine, Packaging, Patients' rights, Pesticides, Pregnant women, Product safety, Public health, Public service advertising, Quality control, Research and development, Restrictive trade practices, Retail trade, Right of privacy, Risk, Sales promotion, Science policy, Smokeless tobacco, Smoking, Smoking and youth, Smuggling, Spices, Standards, State and local government, State laws, Storage, Stroke, Surveys, Tax returns, Taxation, Technological innovations, Technology, Tobacco, Tobacco exports, Tobacco industry, Tobacco research, Trade, Trade regulation, Trade secrets, Trademarks, User charges, Warning labels, Women, Women's health
Latest Action: 08/01/2008 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextTo protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products. 2/15/2007--Introduced. Family Smoking Prevention and Tobacco Control Act - Amends the Federal Food, Drug, and Cosmetic Act to provide for the regulation of tobacco products by the Secretary of Health and Human Services through the Food and Drug Administration, including through disclosure, annual registration, inspection, recordkeeping, and user fee requirements. Sets forth criteria by which tobacco products are deemed adulterated or misbranded. Allows the Secretary to require prior approval of all label statements. Allows the Secretary to restrict the sale or distribution of tobacco products, including advertising and promotion, if the Secretary determines that such regulation would be appropriate for the protection of the public health. Prohibits such regulations from: (1) limiting product sales or distribution to authorization [...] show full description
Also tagged in: Administrative procedure, Aged, Business, Business records, Congress, Congressional reporting requirements, Consumer protection, Consumers, Cost control, Criminal justice, Data banks, Department of Health and Human Services, Drug industry, Drugs, Executive departments, Government information, Government paperwork, Governmental investigations, Health insurance, Health maintenance organizations, Health policy, Identification devices, Import restrictions, Imports, Intellectual property, Labeling, Law, Medical care, Medical economics, Medicare, Medicine, Packaging, Prescription pricing, Product safety, Public contracts, Quality of care, Retiree health benefits, Science policy, Sunset legislation, Technology, Trade
Latest Action: 03/07/2007 - Referred to the Subcommittee on Health. Bill TextTo amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate for lower prices for Medicare prescription drugs and to eliminate the gap in coverage of Medicare prescription drug benefits, to authorize the Secretary of Health and Human Services to promulgate regulations for the reimportation of prescription drugs, and for other purposes. 2/27/2007--Introduced. Medicare Prescription Drug Improvement Act - Amends title XVIII (Medicare) of the Social Security Act to repeal provisions prohibiting the Secretary of Health and Human Services from interfering with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors. Grants the Secretary authority similar to that of the Secretary of Veterans Affairs, Secretary of Defense, and the heads of other Federal agencies and departments that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered Medicare [...] show full description
Also tagged in: Business, Civil liberties, Consumers, Drug advertising, Drug industry, Drugs, Fines (Penalties), Government information, Government publicity, Identification devices, Intellectual property, Labeling, Law, Medical care, Medicine, Packaging, Right of privacy, Technology
Latest Action: 06/14/2007 - Referred to the Subcommittee on Health. Bill TextTo direct the Secretary of Health and Human Services to require the incorporation of counterfeit-resistant technologies into the packaging of prescription drugs, and for other purposes. 6/14/2007--Introduced. Reducing Fraudulent and Imitation Drugs Act of 2007 - Directs the Secretary of Health and Human Services to require prescription drug packaging to incorporate: (1) radio frequency tagging technology or similar trace and track technologies; (2) tamper-indicating technologies; and (3) blister security packaging when possible. Directs the Secretary to: (1) require that such technologies be used exclusively to authenticate the pedigree of prescription drugs; and (2) prohibit such technologies from containing or transmitting any identifying information of a health care practitioner or consumer, or any advertisement or information about indications or off-label uses. Requires the Secretary to encourage prescription drug manufacturers and distributors to incorporate: [...] show full description
Also tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Animals, Antibiotics, Authorization, Budgets, Business, Cancer, Child health, Children, Civil liberties, Clinical trials, Communications, Computer security measures, Conflict of interests, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Data banks, Deceptive advertising, Department of Health and Human Services, Directories, Drug advertising, Drug approvals, Drug industry, Drug interactions, Drugs, Electronic data interchange, Electronic government information, Executive departments, Executive reorganization, Federal advisory bodies, Federal aid to research, Food, Food and Drug Administration (FDA), Food safety, Foreign corporations, Foundations, Fund raising, Gifts, Government information, Government paperwork, Government publicity, Health information systems, Health policy, Identification devices, Imaging systems in medicine, Imports, Intellectual property, Inventions, Inventors, Labeling, Law, Licenses, Medical care, Medical ethics, Medical innovations, Medical instruments and apparatus, Medical records, Medical research, Medical supplies, Medicine, National Institutes of Health (NIH), Nonprofit organizations, Nosocomial infections, Nuclear medicine, Orphan drugs, Patents, Pediatrics, Performance measurement, Pharmaceutical research, Physicians, Product development, Product safety, Profit, Public-private partnerships, Research and development, Research grants, Right of privacy, Risk, Science policy, Small business, Social services, Technology, Telecommunication, Telephone, Television advertising, Trade, User charges, Veterinary medicine
Latest Action: 07/16/2007 - Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 270. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. 7/11/2007--Passed House amended. (There is 1 other summary) Food and Drug Administration Amendments Act of 2007 - Title I: Prescription Drug User Fee Amendments of 2007 - (Sec. 101) Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to include postmarket safety activities within the process for the review of human drug applications or supplements, including: (1) developing and using improved adverse event data collection systems and improved analytical tools to assess potential safety problems; (2) implementing and enforcing provisions relating to postapproval studies, clinical trials, labeling changes, and risk [...] show full description
Also tagged in: Accreditation (Medical care), Actions and defenses, Administrative fees, Administrative procedure, Administrative remedies, Australia, Budgets, Business, Business records, Canada, Checks, Civil liberties, Congress, Congressional reporting requirements, Consumer education, Consumers, Contracts, Credit cards, Criminal justice, Customs administration, Damages, Defective products, Department of Health and Human Services, Directories, Drug advertising, Drug approvals, Drug industry, Drugs, East Asia, Education, Electronic commerce, Electronic data interchange, Electronic funds transfers, Electronic government information, Europe, European Union, Evidence (Law), Executive departments, Export controls, Exports, Federal preemption, Federal Trade Commission, Federal-state relations, Finance, Fines (Penalties), Food and Drug Administration (FDA), Forfeiture, Fraud, Government information, Government paperwork, Government publicity, Governmental investigations, Higher education, Identification devices, Import restrictions, Imports, Independent regulatory commissions, Injunctions, Intellectual property, Interactive media, Internet, Japan, Labeling, Law, Liability (Law), Licenses, Medical associations, Medical care, Medical education, Medical records, Medical tests, Medicine, New Zealand, Oceania, Packaging, Parties to actions, Patent infringement, Patents, Pharmaceutical research, Pharmacies, Pharmacists, Physical examinations, Prescription pricing, Price discrimination, Restrictive trade practices, Right of privacy, Science policy, State and local government, State laws, Surety and fidelity, Switzerland, Technology, Telecommunication, Telephone, Trade, User charges, Web sites, Wholesale trade
Latest Action: 03/07/2007 - Committee on Commerce, Science, and Transportation Subcommittee on Interstate Commerce, Trade, and Tourism. Hearings held. Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. 1/10/2007--Introduced. Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.[...] show full description
Also tagged in: Actions and defenses, Administrative fees, Administrative procedure, Administrative remedies, Africa (Sub-Saharan), Australia, Austria, Belgium, Budgets, Business, Business records, Canada, Congress, Congressional reporting requirements, Consumer education, Consumer protection, Consumers, Damages, Denmark, Department of Health and Human Services, Drug approvals, Drug industry, Drugs, East Asia, Electronic government information, Europe, Evidence (Law), Executive departments, Federal Trade Commission, Federal-state relations, Finland, France, Germany, Government information, Government paperwork, Government publicity, Governmental investigations, Greece, Iceland, Identification devices, Import restrictions, Imports, Independent regulatory commissions, Injunctions, Intellectual property, Internet, Ireland, Israel, Italy, Japan, Labeling, Law, Licenses, Liechtenstein, Limitation of actions, Luxembourg, Medical care, Medicine, Netherlands, New Zealand, Norway, Oceania, Packaging, Parties to actions, Patent infringement, Patents, Pharmacies, Pharmacists, Portugal, Prescription pricing, Price discrimination, Product safety, Punitive damages, Restrictive trade practices, South Africa, Spain, State and local government, Sweden, Switzerland, Technology, Telecommunication, Telephone, Trade, United Kingdom, Web sites, Wholesale trade
Latest Action: 01/10/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. 1/10/2007--Introduced. Pharmaceutical Market Access Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to promulgate regulations permitting pharmacists, pharmacies, and wholesalers to import qualifying drugs from certain countries into the United States. Sets forth registration requirements for exporters. Requires the Secretary to: (1) educate consumers with regard to the availability of qualifying drugs for import for personal use; (2) inspect the facilities and records of importers and registered exporters to ensure compliance with this Act; and (3) establish a registration fee program to collect an annual fee from registered exporters. Deems a prescription drug to be misbranded unless the packaging of such drug complies with the requirements for counterfeit-resistant [...] show full description
|
Latest Legislation - View All
Also tagged in: Americans in foreign countries, Computer crimes, Consumers, Copyright, Criminal justice, Damages, Department of Commerce, Department of Justice, Executive departments, Executive Office of the President, Executive reorganization, Export controls, Federal aid to law enforcement, Federal employees, Fines (Penalties), Foreign aid, Foreign policy, Forfeiture, Government employees, Higher education, Import restrictions, Injunctions, Intellectual property, International affairs, International cooperation, Internet, Labeling, Law, Legal education, Packaging, Patent infringement, Patents, Prosecution, Recruiting of employees, Searches and seizures, Technical assistance, Technology, Telecommunication, Trade, Trademarks
Latest Action: 05/12/2008 - Received in the Senate and Read twice and referred to the Committee on the Judiciary. Bill TextTo enhance remedies for violations of intellectual property laws, and for other purposes. 5/8/2008--Passed House amended. (There are 2 other summaries) Prioritizing Resources and Organization for Intellectual Property Act of 2008 - Title I: Enhancements to Civil Intellectual Property Laws - (Sec. 101) Amends federal copyright law to: (1) provide a safe harbor for copyright registrations that contain inaccurate information, unless there was knowledge of the inaccurate information and the inaccuracy of the information, if known, would have caused the Register of Copyrights to refuse registration; (2) provide that copyright registration requirements apply to civil (not criminal) infringement actions; and (3) require courts to issue protective orders to prevent disclosure of seized records relating to copyright infringement. (Sec. 104) Broadens the trademark infringement situations in which treble damages are allowed to include: (1) intentionally [...] show full description
Also tagged in: Administrative procedure, Administrative remedies, Business, Business records, Communication in medicine, Communications, Consumer protection, Consumers, Criminal investigation, Criminal justice, Criminal justice information, Deceptive advertising, Defective products, Department of Health and Human Services, Directories, Drug adulteration, Drug industry, Drugs, Executive departments, Fines (Penalties), Food and Drug Administration (FDA), Government information, Government paperwork, Government publicity, Governmental investigations, Health education, Identification devices, Informers, Intellectual property, Labeling, Law, Medical care, Medical personnel, Medicine, Packaging, Subpoena, Technology, Wholesale trade
Latest Action: 11/05/2007 - Referred to the House Committee on Energy and Commerce. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. 11/5/2007--Introduced. Tim Fagan's Law or the Counterfeit Drug Enforcement Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to establish a criminal fine and/or imprisonment for a person who: (1) knowingly causes a prescription drug to be adulterated, misbranded, or misrepresented as an approved prescription drug and sells or trades the drug; or (2) purchases or trades for such drug knowing or having reason to know that the drug was knowingly adulterated, misbranded, or misrepresented. Requires a manufacturer of a drug to notify the Secretary of Health and Human Services within 48 hours after first receiving or becoming aware of [...] show full description
Also tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Agriculture, Animals, Antibiotics, Aquaculture, Authorization, Authors and authorship, Budgets, Business, Child health, Children, Civil liberties, Clinical trials, Communicable diseases, Communication in medicine, Communication in science, Communications, Conflict of interests, Congress, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Criminal justice, Criminal justice information, Data banks, Deceptive advertising, Department of Health and Human Services, Direct mail advertising, Directories, Drug advertising, Drug approvals, Drug industry, Drug resistance in microorganisms, Drugs, Electronic data interchange, Electronic government information, Emergency communication systems, Emergency management, Employee training, Environmental assessment, Environmental protection, Executive departments, Executive reorganization, Eye diseases, Federal advisory bodies, Federal employees, Federal officials, Federal preemption, Financial disclosure, Fines (Penalties), Food and Drug Administration (FDA), Food labeling, Food safety, Foundations, Fund raising, Generic drugs, Genetic engineering, Genetic research, Gifts, Government employees, Government information, Government paperwork, Government publicity, Grants-in-aid, Hazardous substances, Health information systems, Health policy, Health surveys, Humanities, Identification devices, Imports, Intellectual property, Internet, Inventors, Job training, Labeling, Law, Local laws, Medical associations, Medical care, Medical ethics, Medical instruments and apparatus, Medical supplies, Medicine, Nonprofit organizations, Nosocomial infections, Orphan drugs, Patents, Pediatrics, Peer review organizations (Medicine), Performance measurement, Pesticides, Pharmaceutical research, Physicians, Product development, Product safety, Public contracts, Public meetings, Public-private partnerships, Radioisotopes in medicine, Research and development, Research grants, Right of privacy, Risk, Science policy, Scientists in government, Seafood, Skin cancer, Small business, Social services, Standards, State and local government, State laws, Technology, Telecommunication, Television advertising, Terrorism, Trade, Trade agreements, Trade negotiations, User charges, Veterinary medicine, Warning labels
Latest Action: 09/27/2007 - Signed by President. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. 9/27/2007--Public Law. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)Food and Drug Administration Amendments Act of 2007 - Title I: Prescription Drug User Fee Amendments of 2007 - (Sec. 101) Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to include postmarket safety activities within the process for the review of human drug applications or supplements, including: (1) developing and using improved adverse event data collection systems and improved analytical tools to assess potential [...] show full description
Also tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Animals, Antibiotics, Authorization, Budgets, Business, Cancer, Child health, Children, Civil liberties, Clinical trials, Communications, Computer security measures, Conflict of interests, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Data banks, Deceptive advertising, Department of Health and Human Services, Directories, Drug advertising, Drug approvals, Drug industry, Drug interactions, Drugs, Electronic data interchange, Electronic government information, Executive departments, Executive reorganization, Federal advisory bodies, Federal aid to research, Food, Food and Drug Administration (FDA), Food safety, Foreign corporations, Foundations, Fund raising, Gifts, Government information, Government paperwork, Government publicity, Health information systems, Health policy, Identification devices, Imaging systems in medicine, Imports, Intellectual property, Inventions, Inventors, Labeling, Law, Licenses, Medical care, Medical ethics, Medical innovations, Medical instruments and apparatus, Medical records, Medical research, Medical supplies, Medicine, National Institutes of Health (NIH), Nonprofit organizations, Nosocomial infections, Nuclear medicine, Orphan drugs, Patents, Pediatrics, Performance measurement, Pharmaceutical research, Physicians, Product development, Product safety, Profit, Public-private partnerships, Research and development, Research grants, Right of privacy, Risk, Science policy, Small business, Social services, Technology, Telecommunication, Telephone, Television advertising, Trade, User charges, Veterinary medicine
Latest Action: 07/16/2007 - Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 270. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. 7/11/2007--Passed House amended. (There is 1 other summary) Food and Drug Administration Amendments Act of 2007 - Title I: Prescription Drug User Fee Amendments of 2007 - (Sec. 101) Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to include postmarket safety activities within the process for the review of human drug applications or supplements, including: (1) developing and using improved adverse event data collection systems and improved analytical tools to assess potential safety problems; (2) implementing and enforcing provisions relating to postapproval studies, clinical trials, labeling changes, and risk [...] show full description
Also tagged in: Business, Civil liberties, Consumers, Drug advertising, Drug industry, Drugs, Fines (Penalties), Government information, Government publicity, Identification devices, Intellectual property, Labeling, Law, Medical care, Medicine, Packaging, Right of privacy, Technology
Latest Action: 06/14/2007 - Referred to the Subcommittee on Health. Bill TextTo direct the Secretary of Health and Human Services to require the incorporation of counterfeit-resistant technologies into the packaging of prescription drugs, and for other purposes. 6/14/2007--Introduced. Reducing Fraudulent and Imitation Drugs Act of 2007 - Directs the Secretary of Health and Human Services to require prescription drug packaging to incorporate: (1) radio frequency tagging technology or similar trace and track technologies; (2) tamper-indicating technologies; and (3) blister security packaging when possible. Directs the Secretary to: (1) require that such technologies be used exclusively to authenticate the pedigree of prescription drugs; and (2) prohibit such technologies from containing or transmitting any identifying information of a health care practitioner or consumer, or any advertisement or information about indications or off-label uses. Requires the Secretary to encourage prescription drug manufacturers and distributors to incorporate: [...] show full description
|
